CellSource Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3423580004
JPY
320.00
7 (2.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Positive results in Apr 26

  • NET PROFIT(HY) Higher at JPY 75.8 MM
  • INTEREST COVERAGE RATIO(Q) Highest at 57,322.8
  • RAW MATERIAL COST(Y) Fallen by -2.3% (YoY)
2

With ROE of 2.03%, it has a very attractive valuation with a 0.99 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 6,530 Million (Micro Cap)

stock-summary
P/E

49.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.80

stock-summary
Return on Equity

2.03%

stock-summary
Price to Book

1.09

Revenue and Profits:
Net Sales:
916 Million
(Quarterly Results - Apr 2026)
Net Profit:
38 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.6%
0%
-11.6%
6 Months
-19.4%
0%
-19.4%
1 Year
-54.15%
0%
-54.15%
2 Years
-75.35%
0%
-75.35%
3 Years
-84.29%
0%
-84.29%
4 Years
-93.42%
0%
-93.42%
5 Years
-97.7%
0%
-97.7%

CellSource Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
9.66%
EBIT Growth (5y)
-15.79%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
0.68
Tax Ratio
63.77%
Dividend Payout Ratio
929.37%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
89.35%
ROE (avg)
16.26%

Valuation key factors

Factor
Value
P/E Ratio
49
Industry P/E
Price to Book Value
0.99
EV to EBIT
4.10
EV to EBITDA
2.40
EV to Capital Employed
0.94
EV to Sales
0.31
PEG Ratio
0.17
Dividend Yield
NA
ROCE (Latest)
22.83%
ROE (Latest)
2.03%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Apr 2026 is 6.47% vs -3.74% in Jan 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Apr 2026 is 11.90% vs 144.44% in Jan 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Apr'26",
        "Jan'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "915.60",
          "val2": "860.00",
          "chgp": "6.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "110.60",
          "val2": "103.40",
          "chgp": "6.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.30",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.70",
          "val2": "-6.20",
          "chgp": "88.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "37.60",
          "val2": "33.60",
          "chgp": "11.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "72.20%",
          "val2": "69.30%",
          "chgp": "0.29%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Oct'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Oct 2025 is -14.78% vs -3.45% in Oct 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Oct 2025 is -95.50% vs -74.23% in Oct 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Oct'25",
        "Oct'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,711.50",
          "val2": "4,355.10",
          "chgp": "-14.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "371.00",
          "val2": "282.40",
          "chgp": "31.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "1.40",
          "chgp": "-7.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-38.20",
          "val2": "10.20",
          "chgp": "-474.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.70",
          "val2": "237.90",
          "chgp": "-95.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "44.90%",
          "val2": "29.70%",
          "chgp": "1.52%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Apr'26 - QoQstock-summary

Apr'26
Jan'26
Change(%)
Net Sales
915.60
860.00
6.47%
Operating Profit (PBDIT) excl Other Income
110.60
103.40
6.96%
Interest
0.20
0.30
-33.33%
Exceptional Items
-0.70
-6.20
88.71%
Consolidate Net Profit
37.60
33.60
11.90%
Operating Profit Margin (Excl OI)
72.20%
69.30%
0.29%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Apr 2026 is 6.47% vs -3.74% in Jan 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Apr 2026 is 11.90% vs 144.44% in Jan 2026

Annual Results Snapshot (Consolidated) - Oct'25stock-summary

Oct'25
Oct'24
Change(%)
Net Sales
3,711.50
4,355.10
-14.78%
Operating Profit (PBDIT) excl Other Income
371.00
282.40
31.37%
Interest
1.30
1.40
-7.14%
Exceptional Items
-38.20
10.20
-474.51%
Consolidate Net Profit
10.70
237.90
-95.50%
Operating Profit Margin (Excl OI)
44.90%
29.70%
1.52%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Oct 2025 is -14.78% vs -3.45% in Oct 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Oct 2025 is -95.50% vs -74.23% in Oct 2024

stock-summaryCompany CV
About CellSource Co., Ltd. stock-summary
stock-summary
CellSource Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available